-
公开(公告)号:BR0307465A
公开(公告)日:2004-11-09
申请号:BR0307465
申请日:2003-02-04
Applicant: SERVIER LAB
Inventor: DASSONVILLE ALEXANDRA , BRETECHE ANNE , DUFLOS MURIEL , BAUT GUILLAUME LE , PFEIFFER BRUNO , RENARD PIERRE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE
IPC: A61K31/122 , A61K31/222 , A61K31/4402 , A61P3/10 , C07C45/00 , C07C45/28 , C07C46/00 , C07C46/10 , C07C50/28 , C07C50/30 , C07D213/50
Abstract: Compound of formula (I): wherein: R 1 and R 2 , which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R 4 represents hydrogen or alkyl, R 5 represents hydrogen, alkyl, aryl or heteroaryl, R 3 represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R 3 represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia.
-
公开(公告)号:ZA200308629B
公开(公告)日:2004-11-05
申请号:ZA200308629
申请日:2003-11-05
Applicant: SERVIER LAB
Inventor: HUSSON HENRI-PHILIPPE , GIORGI-RENAULT SYLVIANE , DESBENE STEPHANIE , HICKMAN JOHN , PIERRE ALAIN , KRAUS-BERTHIER LAURENCE , PFEIFFER BRUNO , RENARD PIERRA
IPC: C07D491/048 , A61K31/4741 , A61K31/4743 , A61K31/4745 , A61P35/00 , C07D491/04 , C07D491/14 , C07D491/147 , C07D491/153 , C07D497/14 , C07D
Abstract: Compound of formula (I): wherein: represents a single or double bond, represents a ring system selected from R6a, R6b, R6c, R6d, X and Y are as defined in the description, R1 represents a hydrogen atom or a group selected from aryl, heteroaryl, cycloalkyl, optionally substituted alkyl, and COR8 wherein R8 is as defined in the description, R2, R3, R4 and R5, which may be the same or different, each represent: a hydrogen atom, a halogen atom, an alkyl group,. an alkoxy group, a hydroxy group, a polyhaloalkyl group, a nitro group, an optionally substituted amino group, a group of formula wherein m represents an integer such that 1
-
公开(公告)号:BR0213403A
公开(公告)日:2004-11-03
申请号:BR0213403
申请日:2002-10-21
Applicant: SERVIER LAB
Inventor: PRUDHOMME MICHELLE , MARMINON CHRISTELLE , MOREAU PASCALE , HICKMAN JOHN , PIERRE ALAIN , PFEIFFER BRUNO , RENARD PIERRE , BIZOT-ESPIARD JEAN-GUY
IPC: A61K31/7056 , A61P3/04 , A61P3/10 , A61P25/00 , A61P25/16 , A61P25/28 , A61P35/00 , A61P43/00 , C07H19/23
Abstract: Compound of formula (I): wherein: R1 and R2 each represents a group selected from hydrogen, alkyl, arylalkyl, hydroxy, hydroxyalkyl, dihydroxyalkyl, alkoxy, alkoxyalkyl, amino and aminoalkyl (optionally substituted), Ra and Rb each represents an alkylene chain, X1, X2 and X3 each represents a group selected from hydroxy, alkoxy, aryloxy, arylalkoxy, alkyl, amino (optionally substituted), halogen, alkylcarbonyloxy and azido, X4 represents a methylidene group or a group of formula -Rc-X1 as defined in the description, their isomers and also their addition salts with a pharmaceutically acceptable acid or base.
-
公开(公告)号:HU0400347A2
公开(公告)日:2004-09-28
申请号:HU0400347
申请日:2002-06-28
Applicant: SERVIER LAB
Inventor: PRUDHOMME MICHELLE , MARMINON CHRISTELLE , ROUTIER SYLVAIN , COUDERT GERARD , MEROUR JEAN-YVES , HICKMAN JOHN , PIERRE ALAIN , RENARD PIERRE , PFEIFFER BRUNO
IPC: C07H19/23 , A61K31/706 , A61P35/00 , C07H15/252 , C07D471/22
Abstract: Compounds of formula (I):
-
公开(公告)号:DE60012287D1
公开(公告)日:2004-08-26
申请号:DE60012287
申请日:2000-10-27
Applicant: SERVIER LAB
Inventor: MONNERET CLAUDE , BERTOUNESQUE EMMANUEL , MERESSE PHILIPPE , ATASSI GHANEM , PIERRE ALAIN , PFEIFFER BRUNO , RENARD PIERRE
IPC: C07D493/06 , A61K31/357 , A61K31/36 , A61K31/365 , A61K31/70 , A61P35/00 , C07B61/00 , C07D493/04 , C07D519/00 , C07H17/04
Abstract: 9-(3,5-Dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro (3',4':6,7)-naphtho(2,3-d)(1,3)-dioxol-6(5aH)-one derivatives (I) are new. Podophyllotoxin derivatives of formula (I) and their isomers and acid or base addition salts are new. R = -A-G or a bicyclic group of formula (a); X,Y = H, OH, alkoxy, NH2 or mono- or di-alkylamino; W = H, alkyl, aryl or heteroaryl; A = a direct bond or optionally unsaturated 1-6C alkylene (optionally substituted (os) by one or more of halo and OH); G = H, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, OR2, -O-T1-NR3R4, -O-T1-NR2-T1'-NR3R4, NR3R4, -NR2-T1-NR3R4, -NR2-T1-OR5, -NR2-T1-COOR6, -NR2-T1-COR6, -CONR3R4, -CO-NR2-T2, -O-CO-NR2-T2, -O-CS-NR2-T2, -NR2-CO-T2, -NR2-CS-T2, -OCOOT2, -OCONR2-T2, -OC(S)OT2, -OC(S)NR2-T2, -NR2-COOT2, -NR2-CO-NR6-T2, -NR2-C(S)OT2, -NR2-CS-NR6-T2 or -NR2-SO2T3; R2 = H, alkyl, aryl or arylalkyl; T1, T1' = 1-6C alkylene; R3, R4 = H, alkyl (os by one or more OH), aryl, arylalkyl, cycloalkyl, heteroarylalkyl, heteroaryl, heterocycloalkyl or heterocycloalkylalkyl, or NR3R4 = 5-7 membered heterocyclyl, optionally containing a second O or N heterocyclyl and os by one or more of halo, OH, alkyl and heterocyclyl; R5 = alkyl, aryl or arylalkyl; T2 = H, alkyl (os by one or more halo), aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl or heterocycloalkylalkyl; or 1-6C alkylene substituted by one or more of NR3R4, OR2, COOR6, NR2COR6, NR2COOR6, COR6, CONR3R4, -NR2-T1-NR3R4, -NR2-T1-OR6 or -O-T1-NR3R4; T3 = 1-20C alkyl (os by one or more of halo, OR2, NR2R6, NO2, CN or N3), aryl, arylalkyl, cycloalkyl, cycloalkylakyl, heterocycloalkyl, heterocycloalkylalkyl, heteroaryl or heteroarylalkyl; R1 = H, alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, heterocycloalkylcarbonyl, alkylsulfonyl, arylsulfonyl, arylalkylasulfonyl, phosphono, alkoxycarbonyl, aryloxycarbonyl or arylalkoxycarbonyl; aryl moieties = phenyl, biphenyl, naphthyl, di- or tetra-hydronaphthyl, indenyl or indanyl (all os by one or more of halo, OH, alkyl, alkoxy, CN, NO2, NH2, mono- or dialkylamino, alkylsulfonyl, alkylsulfonylamino, COOH, alkoxycarbonyl, aryloxycarbonyl, arylalkoxycarbonyl, hydroxyalkyl, trihaloalkyl, OCH2O, OCH2CH2O, morpholinyl, piperidyl, piperazinyl, alkylcarbonyloxy or alkylcarbonyl); heteroaryl moieties = 5-12 membered mono- or bi-cyclic aromatic system (where one ring of a bicyclic system is optionally partially hydrogenated), containing 1-3 of O, N and S as heteroatom(s) and os as for aryl; cycloalkyl moieties = 3-10C mono- or bi-cyclic saturated or unsaturated (but not aromatic) system (os by one or more of halo, alkyl, trihaloalkyl, OH, hydroxyalkyl, NH2, mono- or dialkylamino, piperidyl, piperazinyl and morpholinyl), and heterocycloalkyl moieties = as for cycloalkyl but containing 1 or 2 of O, N and S as heteroatom(s); provided that R1 is not Me if R is H; alkyl moieties have 1-6C unless specified otherwise. Independent claims are included for the following: (i) new intermediates (A), having formula as for (I) but with R replaced by N3, Cl, Br or -A1-CHO (A1 = 1-5C alkylene); and (ii) preparation of (I).
-
公开(公告)号:NO20043532L
公开(公告)日:2004-08-24
申请号:NO20043532
申请日:2004-08-24
Applicant: SERVIER LAB
Inventor: RENARD PIERRE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , DUFLOS MURIEL , PFEIFFER BRUNO , DASSONVILLE ALEXANDRA , BRETECHE ANNE , BAUT GUILLAUME LE
IPC: A61K31/122 , A61K31/222 , A61K31/4402 , A61P3/10 , C07C45/00 , C07C45/28 , C07C46/00 , C07C46/10 , C07C50/28 , C07C50/30 , C07D213/50
Abstract: Compound of formula (I): wherein: R 1 and R 2 , which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R 4 represents hydrogen or alkyl, R 5 represents hydrogen, alkyl, aryl or heteroaryl, R 3 represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R 3 represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia.
-
公开(公告)号:CA2513059A1
公开(公告)日:2004-08-19
申请号:CA2513059
申请日:2004-02-03
Applicant: SERVIER LAB
Inventor: CARATO PASCAL , FLOUQUET NATHALIE , PIERRE ALAIN , BERTHELOT PASCAL , PFEIFFER BRUNO , RENARD PIERRE , LEBEGUE NICOLAS , HICKMAN JOHN , GALLET SEBASTIEN
IPC: A61P35/00 , C07D513/04 , C07D515/04 , A61K31/55
-
公开(公告)号:AT271558T
公开(公告)日:2004-08-15
申请号:AT00402985
申请日:2000-10-27
Applicant: SERVIER LAB
Inventor: MONNERET CLAUDE , BERTOUNESQUE EMMANUEL , MERESSE PHILIPPE , ATASSI GHANEM , PIERRE ALAIN , PFEIFFER BRUNO , RENARD PIERRE
IPC: C07D493/06 , A61K31/357 , A61K31/36 , A61K31/365 , A61K31/70 , A61P35/00 , C07B61/00 , C07D493/04 , C07D519/00 , C07H17/04
Abstract: 9-(3,5-Dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro (3',4':6,7)-naphtho(2,3-d)(1,3)-dioxol-6(5aH)-one derivatives (I) are new. Podophyllotoxin derivatives of formula (I) and their isomers and acid or base addition salts are new. R = -A-G or a bicyclic group of formula (a); X,Y = H, OH, alkoxy, NH2 or mono- or di-alkylamino; W = H, alkyl, aryl or heteroaryl; A = a direct bond or optionally unsaturated 1-6C alkylene (optionally substituted (os) by one or more of halo and OH); G = H, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, OR2, -O-T1-NR3R4, -O-T1-NR2-T1'-NR3R4, NR3R4, -NR2-T1-NR3R4, -NR2-T1-OR5, -NR2-T1-COOR6, -NR2-T1-COR6, -CONR3R4, -CO-NR2-T2, -O-CO-NR2-T2, -O-CS-NR2-T2, -NR2-CO-T2, -NR2-CS-T2, -OCOOT2, -OCONR2-T2, -OC(S)OT2, -OC(S)NR2-T2, -NR2-COOT2, -NR2-CO-NR6-T2, -NR2-C(S)OT2, -NR2-CS-NR6-T2 or -NR2-SO2T3; R2 = H, alkyl, aryl or arylalkyl; T1, T1' = 1-6C alkylene; R3, R4 = H, alkyl (os by one or more OH), aryl, arylalkyl, cycloalkyl, heteroarylalkyl, heteroaryl, heterocycloalkyl or heterocycloalkylalkyl, or NR3R4 = 5-7 membered heterocyclyl, optionally containing a second O or N heterocyclyl and os by one or more of halo, OH, alkyl and heterocyclyl; R5 = alkyl, aryl or arylalkyl; T2 = H, alkyl (os by one or more halo), aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl or heterocycloalkylalkyl; or 1-6C alkylene substituted by one or more of NR3R4, OR2, COOR6, NR2COR6, NR2COOR6, COR6, CONR3R4, -NR2-T1-NR3R4, -NR2-T1-OR6 or -O-T1-NR3R4; T3 = 1-20C alkyl (os by one or more of halo, OR2, NR2R6, NO2, CN or N3), aryl, arylalkyl, cycloalkyl, cycloalkylakyl, heterocycloalkyl, heterocycloalkylalkyl, heteroaryl or heteroarylalkyl; R1 = H, alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, heterocycloalkylcarbonyl, alkylsulfonyl, arylsulfonyl, arylalkylasulfonyl, phosphono, alkoxycarbonyl, aryloxycarbonyl or arylalkoxycarbonyl; aryl moieties = phenyl, biphenyl, naphthyl, di- or tetra-hydronaphthyl, indenyl or indanyl (all os by one or more of halo, OH, alkyl, alkoxy, CN, NO2, NH2, mono- or dialkylamino, alkylsulfonyl, alkylsulfonylamino, COOH, alkoxycarbonyl, aryloxycarbonyl, arylalkoxycarbonyl, hydroxyalkyl, trihaloalkyl, OCH2O, OCH2CH2O, morpholinyl, piperidyl, piperazinyl, alkylcarbonyloxy or alkylcarbonyl); heteroaryl moieties = 5-12 membered mono- or bi-cyclic aromatic system (where one ring of a bicyclic system is optionally partially hydrogenated), containing 1-3 of O, N and S as heteroatom(s) and os as for aryl; cycloalkyl moieties = 3-10C mono- or bi-cyclic saturated or unsaturated (but not aromatic) system (os by one or more of halo, alkyl, trihaloalkyl, OH, hydroxyalkyl, NH2, mono- or dialkylamino, piperidyl, piperazinyl and morpholinyl), and heterocycloalkyl moieties = as for cycloalkyl but containing 1 or 2 of O, N and S as heteroatom(s); provided that R1 is not Me if R is H; alkyl moieties have 1-6C unless specified otherwise. Independent claims are included for the following: (i) new intermediates (A), having formula as for (I) but with R replaced by N3, Cl, Br or -A1-CHO (A1 = 1-5C alkylene); and (ii) preparation of (I).
-
公开(公告)号:FR2850654A1
公开(公告)日:2004-08-06
申请号:FR0301181
申请日:2003-02-03
Applicant: SERVIER LAB
Inventor: GALLET SEBASTIEN , BERTHELOT PASCAL , LEBEGUE NICOLAS , FLOUQUET NATHALIE , CARATO PASCAL , HICKMAN JOHN , PIERRE ALAIN , PFEIFFER BRUNO , RENARD PIERRE
IPC: A61P35/00 , C07D513/04 , C07D515/04 , A61K31/554
Abstract: A compound of formula (I): wherein: represents benzo or pyrido, optionally fused in the 2-3, 3-4 or 4-5 position to a phenyl, (C 4 -C 8 )cycloalkyl or heterocyclic group, which may be optionally substituted, W represents X-Y or Y-X, wherein: X represents and Y represents oxygen or N-R 3 , n represents zero or an integer from 1 to 6, G, R 1 , R 2 and R 3 are as defined in the description, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful for the treatment of cancerous diseases.
-
公开(公告)号:BR0304575A
公开(公告)日:2004-07-20
申请号:BR0304575
申请日:2003-10-15
Applicant: SERVIER LAB
Inventor: PRUDHOMME MICHELLE , HUGON BERNADETTE , ANIZON FABRICE , HICKMAN JOHN , PIERRE ALAIN , GOLSTEYN ROY , RENARD PIERRE , PFEIFFER BRUNO
IPC: A61K31/40 , A61K31/407 , A61K31/437 , A61K31/7056 , A61K31/706 , A61P35/00 , A61P43/00 , C07D471/22 , C07D487/14 , C07D491/14 , C07D491/147 , C07H19/23 , C07D487/22 , C07D407/04
Abstract: (3,4-a:3,4-c) Carbazole derivatives (I), their enantiomers, diastereoisomers and salts with acids and bases. (3,4-a:3,4-c) Carbazole derivatives of formula (I), their enantiomers, diastereoisomers and salts with acids and bases A = ring that is saturated, partially, or fully unsaturated, and that may be aromatic; W' = phenyl or pyridinyl; Z' = U'-V', methylene dioxy or ethylenedioxy; U' = bond, 1-6C alkylene, 2-6C alkenylene, optionally substituted by 1 or 2 halo or OH groups; V' = H, halo, CN, NO2, azido, 1-6C alkyl or alkoxy, aryl, aralkyl, OH, aryloxy, arylalkoxy, formyl, COOH, NH2CO, NR3R4, -C(O)-T1, -C(O)-NR3-T1, NR3C(O)T1, -O-C(O)-T1, -C(O)-OT1, -NR3-T2-NR3R4, -NR3-T2-OR3, -NR3-T2-COOR3, -O-T'2-NR3R4, -O-T'2-OR3, -O-T'2-COOR3, or -S(O)t-R3; R3, R4 = H, 1-6C alkyl, aryl, aralkyl or together form 5-10 membered saturated mono or bicyclic heterocycle, optionally with a second hetero atom (O or N) and optionally substituted by alkyl, aryl, aralkyl, OH, alkoxy, amino mono- or dialkylamino; T1 = alkyl (optionally substituted by -OR3, -NR3R4, -COOR3, -C(O)R3, or -C(O)NR3R4), 2-6C alkenyl, optionally substituted; T2 = 1-6C alkylene; T'2 = 1-6C alkylene optionally substituted by one or more OH groups; t = 0, 1, or 2; Q1 = O or NR2; R2 = H, 1-6C alkyl, aryl, aralkyl, cycloalkyl, cycloalkyl alkyl, -OR3, -NR3R4, -O-T2-NR3R4, NR3-T2-NR3R4, mono- or di-hydroxyalkylamino, -C(O)R3, -NH-C(O)-R3, or 1-6C alkylene optionally substituted by halo, CN, NO2, -OR3, -NR3R4, -COOR3, -C(O)R3, hydroxyalkylamino, dihydroxyalkylamino, -C(O)-NHR3; Q2 = O or NR'2; R'2 = H, 1-6C alkyl, aryl, aralkyl, cycloalkyl, cycloalkyl alkyl, -OR3, -NR3R4, -O-T2-NR3R4, NR3-T2-NR3R4, mono- or di-hydroxyalkylamino, -C(O)R3, -NH-C(O)-R3, or 1-6C alkylene optionally substituted by halo, CN, NO2, -OR3, -NR3R4, -COOR3, -C(O)R3, hydroxyalkylamino, dihydroxyalkylamino, -C(O)-NHR3; X1 = H, OH, alkoxy, mercapto, alkylthio; Y1 = H or X1 and Y1 together form carbonyl or thiocarbonyl; X2 = H, OH, alkoxy, mercapto, alkylthio; Y2 = H or X2 and Y2 together form carbonyl or thiocarbonyl; X'1 = H, OH, alkoxy, mercapto, alkylthio; Y'1 = H or X'1 and Y'1 together form carbonyl or thiocarbonyl; X'2 = H, OH, alkoxy, mercapto, alkylthio; Y'2 = H or X'2 and Y'2 together form carbonyl or thiocarbonyl; R1 = H, 1-6C alkyl (optionally substituted by one or more OH, alkoxy, hydroxyalkoxy, or NR3R4 groups) or it is a group of formula (a); Ra - Rd = a bond, H, halo, OH, alkoxy, aryloxy, arylalkoxy, alkyl, aralkyl, aryl, -NR3R4, azido, -N=NR3, or -O-C(O)-R5; R5 = alkyl optionally substituted by one or more halo, OH, amino, mono- or dialkylamino, aryl, aralkyl, cycloalkyl, or heterocycloalkyl; Re = methylene or -U1-Ra; U1 = a bond or methylene; and n = 0 or 1. with the proviso that the following compounds are not within the scope of (I): 3b, 6a, 6b, 7-tetrahydro-1H-dipyrrolo(3,4-a:3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone; 5-ethyl-3b, 6a, 6b, 7-tetrahydro-1H-dipyrrolo(3,4-a:3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone; 3b, 6a, 7, 11c-tetrahydro-1H-dipyrrolo(3,4-a:3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone; and 3b, 6a, 6b, 7-tetrahydrofuro(3,4a)pyrrolo(3,4-c) carbazole-1,3,4,6(2H, 3aH, 5H)-tetrone.
-
-
-
-
-
-
-
-
-